Sangeeta Bhaskar
New Delhi, DL, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
PreVenTB trial: protocol for evaluation of efficacy and safety of two vaccines VPM1002 and Immuvac (Mw) in preventing tuberculosis (TB) in healthy household contacts of newly diagnosed sputum smear-positive pulmonary TB patients: phase III, randomised, double-blind, three-arm placebo-controlled trial.
Journal: BMJ open
Published: December 07, 2024
Mycobacterium indicus pranii therapy suppresses systemic dissemination of tumor cells in B16F10 murine model of melanoma.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 23, 2022
Type 1 interferon mediated signaling is indispensable for eliciting anti-tumor responses by Mycobacterium indicus pranii.
Journal: Frontiers in immunology
Published: November 21, 2022
Tumor targeted delivery of mycobacterial adjuvant encapsulated chitosan nanoparticles showed potential anti-cancer activity and immune cell activation in tumor microenvironment.
Journal: International immunopharmacology
Published: June 15, 2022
Macrophages Are the Key Players in Promoting Hyper-Inflammatory Response in a Mouse Model of TB-IRIS.
Journal: Frontiers in immunology
Published: September 13, 2021
Mycobacterium indicus pranii Induced Memory T-Cells in Lung Airways Are Sentinels for Improved Protection Against M.tb Infection.
Journal: Frontiers in immunology
Published: June 03, 2019
Mycobacterium indicus pranii therapy induces tumor regression in MyD88- and TLR2-dependent manner.
Journal: BMC research notes
Published: February 18, 2019
Myeloid differentiation primary response protein 88 (MyD88)-deficient dendritic cells exhibit a skewed cytokine response to BCG.
Journal: BMC research notes
Published: November 29, 2018
Methods for Detection of Autophagy in Mammalian Cells.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: September 23, 2018
Cell wall fraction of Mycobacterium indicus pranii shows potential Th1 adjuvant activity.
Journal: International immunopharmacology
Published: August 20, 2018
Last Updated: 09/26/2026